Financhill
Back

Nuvalent Vs. Syndax Pharmaceuticals Industry Stock Comparison

Sell
47

NUVL
Nuvalent

Last Price:
65.57
Seasonality Move:
36.5%
Sell
40

SNDX
Syndax Pharmaceuticals

Last Price:
19.25
Seasonality Move:
1.81%
Sell
47
Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

  • The current Nuvalent [NUVL] share price is $65.62. The Score for NUVL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Syndax Pharmaceuticals (SNDX) is a Sell

Is Syndax Pharmaceuticals a Buy, Sell or Hold?

  • The current Syndax Pharmaceuticals [SNDX] share price is $19.27. The Score for SNDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

  • The Nuvalent share price today is $65.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUVL is experiencing slight selling pressure.

SNDX Stock Price Chart

What is Syndax Pharmaceuticals's stock price today?

  • The Syndax Pharmaceuticals share price today is $19.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.

NUVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 40.98 Sell
Chaikin Money Flow: -10992 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.5 - 70.72) Sell
Bollinger Bands (100): (67.91 - 81.95) Sell

SNDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 34.19 Sell
Chaikin Money Flow: -399510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.09 - 22.09) Sell
Bollinger Bands (100): (20.72 - 23.2) Sell

NUVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.41 Sell
20-day SMA: 68.42 Sell
50-day SMA: 69.34 Sell
200-day SMA: 65.95 Sell
8-day EMA: 67.17 Sell
20-day EMA: 68.1 Sell
50-day EMA: 70.07 Sell
200-day EMA: 65.19 Buy

SNDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.02 Sell
20-day SMA: 21 Sell
50-day SMA: 21.6 Sell
200-day SMA: 19.16 Buy
8-day EMA: 19.92 Sell
20-day EMA: 20.6 Sell
50-day EMA: 21.26 Sell
200-day EMA: 20.59 Sell

Nuvalent Earnings Growth & NUVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.66 per share.

Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.64 per share, and an increase next year of $0.76 per share.

Nuvalent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Syndax Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):